Company Encyclopedia
View More
name
CannaPharmaRX, Inc.
CPMD.US
CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Canada. It produces and sells dried cannabis flower. The company is based in Calgary, Canada.
4.722 T
CPMD.USMarket value -Rank by Market Cap -/-

Financial Score

29/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking103/186
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE36.29%A
    • Profit Margin-429.32%E
    • Gross Margin-67.01%E
  • Growth ScoreB
    • Revenue YoY404.63%A
    • Net Profit YoY-630.62%E
    • Total Assets YoY-0.55%D
    • Net Assets YoY-35.77%E
  • Cash ScoreB
    • Cash Flow Margin-23.29%D
    • OCF YoY404.63%A
  • Operating ScoreE
    • Turnover0.15E
  • Debt ScoreE
    • Gearing Ratio293.83%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CannaPharmaRX, Inc. | 10-Q: FY2025 Q3 Revenue: USD 656.61 K

    LB filings·
    US
    CPMD
    +9.09%
    LB filings·
    US
    CPMD
    +9.09%

    CannaPharmaRX, Inc. | 10-Q: FY2025 Q2 Revenue: USD 231.61 K

    LB filings·
    US
    CPMD
    +9.09%
    LB filings·
    US
    CPMD
    +9.09%

    CannaPharmaRX, Inc. | 10-Q: FY2025 Q1 Revenue: USD 335.32 K

    LB filings·
    US
    CPMD
    +9.09%
    LB filings·
    US
    CPMD
    +9.09%
    © 2025 Longbridge｜Disclaimer